SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000912282-09-000132
Filing Date
2009-02-05
Accepted
2009-02-04 19:25:40
Documents
3
Period of Report
2009-02-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 oncogenex8k_02042009.htm 8-K 16957
2 PRESS RELEASE DATED FEBRUARY 4, 2009 ex99_1.htm EX-99.1 16557
3 GRAPHIC img1.jpg GRAPHIC 3348
  Complete submission text file 0000912282-09-000132.txt   39861
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 09569679
SIC: 2835 In Vitro & In Vivo Diagnostic Substances